Selected Grants
Targeted Radiolabeled PARP inhibitors (PARPi) -Site-specific radiolabeling
ResearchPrincipal Investigator · Awarded by Zentera Alpha, Inc · 2022 - 2026PSMAi-PARPi combination agents for the targeted Auger and alpha therapy of metastatic castration-resistant prostate cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025Astatine And Iodine Radiolabeled Monoclonal Antibodies
ResearchCo Investigator · Awarded by National Institutes of Health · 1985 - 2021Labeling nanobodies with 18F residualizing labels for HER2 specific PET imaging
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2021Cereius research agreement
ResearchPrincipal Investigator · Awarded by Cereius Inc. · 2017 - 2019Targeted Radiolabeled PARP inhibitors (PARPi) -Site-specific radiolabeling
ResearchPrincipal Investigator · Awarded by Zentera Alpha, Inc · 2022 - 2026PSMAi-PARPi combination agents for the targeted Auger and alpha therapy of metastatic castration-resistant prostate cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025Astatine And Iodine Radiolabeled Monoclonal Antibodies
ResearchCo Investigator · Awarded by National Institutes of Health · 1985 - 2021Labeling nanobodies with 18F residualizing labels for HER2 specific PET imaging
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2021Cereius research agreement
ResearchPrincipal Investigator · Awarded by Cereius Inc. · 2017 - 2019Development of Tethered Hsp90 Inhibitors Carrying Radioiodinated Probes to Specifically Discriminate and Kill Malignant Breast Tumor Cells
ResearchInvestigator · Awarded by Department of Defense · 2015 - 2019Novel Radiohalogenation Strategies for Enhancing Imaging and Targeted Radiotherapy with Ultrasmall Dual- Modality Silica Nanoparticles (C Dots)
ResearchCo-Principal Investigator · Awarded by Memorial Sloan-Kettering Cancer Center · 2016 - 2018Development of a Targeted Radionuclide Therapy for Triple Negative Breast Cancer
ResearchPrincipal Investigator · Awarded by OncoTAb, Inc. · 2016 - 2017Research Training In Neuro-Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1998 - 2016Enhancing the efficacy of targeted radiotherapy for neuroblastoma
ResearchPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2013 - 2014Cross-disciplinary Training in Medical Physics
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2007 - 2013Brain Tumors - Immunological and Biological Studies
ResearchInvestigator · Awarded by National Institutes of Health · 2001 - 2013Small Animal PET / CT Molecular Imaging
EquipmentMajor User · Awarded by National Institutes of Health · 2011 - 2012Radionuclide-based Molecular Imaging of the DNA Repair Protein AGT
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2011Astatine-211 Radiochemistry: The Development of Methodologies for High Activity Level Radio-Synthesis
ResearchCo Investigator · Awarded by Department of Energy · 2008 - 2010Research Training In Neuro-Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2005 - 2010Imaging of O6-Alkylguianine-DNA Alkyltransferase
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2007Targeted Radiotherapeutics: Chemical and Biological Aspects
ResearchInvestigator · Awarded by Department of Energy · 2004 - 2006Astatine-211 & Radioiodine Labeled Octreotide Conjugates
ResearchAssociate in Research · Awarded by National Institutes of Health · 2001 - 2006Anti-Tenascin Antibody Constructs
ResearchCo Investigator · Awarded by Department of Energy · 1995 - 2005Molecular Imaging Center Planning Grant
ResearchProject Leader · Awarded by National Institutes of Health · 2000 - 2004Astatine And Iodine Radiolabeled Monoclonal Antibodies
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1999 - 2004MIBG Analogue Radiopharmaceuticals
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1997 - 2003Brain Tumors--Immunological and Biological Studies
ResearchInvestigator · Awarded by National Institutes of Health · 1976 - 2001Brain Tumors - Immunological And Biological Studies
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1997 - 1999Src On Primary And Matastatic Tumors Of The Cns
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1994 - 1999Astatine And Iodine Radiolabeled Monoclonal Antibodies
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1994 - 1999Astatine And Iodine Radiolabeled Monoclonal Antibodies
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1993 - 1999Astatine And Iodine Radiolabeled Monoclonal Antibodies
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1985 - 1999Positron Emission Imaging Of Tumors Using Monoclonal Antib
ResearchCo-Principal Investigator · Awarded by Department of Energy · 1995 - 1998Migb And Analogs For Diagnosis And Therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1994 - 1998Mibg And Analogs For Diagnosis And Therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1993 - 1998Mibg And Analogs For Diagnosis And Therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1993 - 1998Migb And Analogs For Diagnosis And Therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1993 - 1998Cancer And Leukemia Group B Statistical Center
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1992 - 1993External Relationships
- Cereius
- Z-Alpha, Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.